Scholars Central

Conference abstractPublished 9 Oct 2019

Pharmacological advice for clinical practice

Authors: Shirley Taniguchi

University of Sao Paulo, Brazil

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Treating drugs symptomatically, reversing drug side effects without considering the receptors involved, and combining drugs without following specific criteria, may result in inefficient attempts to resolve clinical events. Methodology & Theoretical Orientation: This was a retrospective survey of patients hospitalized in a large general hospital located in the city of São Paulo (Brazil) and individual patients treated at several hospitals in the region. Findings: Difficult to control bleeding may occur with the administration of cardiotonic agents (phosphodiesterase inhibitors) in patients submitted to surgery. Combining anticoagulants with drugs with a high albumin binding rate may also cause significant bleeding. blockers such as phenytoin without accompanying cardiac function may Intravenous administration of voltage-dependent sodium channel lead to arrhythmia and difficult to reverse cardiac arrest Administering depressant drugs to contain akathisia caused by neuroleptics may result in a significant reduction of consciousness levels. Treating immediate postoperative period opioid hallucinations with typical neuroleptics may cause motor agitation that could significantly affect the surgical procedure Treating L-Dopa hallucinations with neuroleptics may cause motor side effects contributing to the motor difficulties associated with Parkinson's disease. Treating confusion with neuroleptics may increase the motor side effects associated with the use of central acting anticholinesterase inhibitors or cholinergic agonists in patients with Alzheimer's disease. Conclusion & Significance: An individualized medical prescription should contain drugs selected based on their mechanism of action, half life, albumin binding rate, and predicted side effects. This would help reduce risks and increase the chances of therapeutic success.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Shirley Taniguchi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels